Latest News - Galderma

Thursday, April 06, 2017 | Phase 3/4 Trials, PracticalDermatology.com, Galderma

Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit in Phase 4 Studies

Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that…

Read the full story

Thursday, March 02, 2017 | PracticalDermatology.com, Galderma

Galderma Rolls Out Restylane Refyne, Defyne

With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --Restylane Refyne and Restylane Defyne  …

Read the full story

Thursday, March 02, 2017 | Personnel/Company News, Practice Development, Galderma, Modernizing Medicine

Modernizing Medicine and Galderma Collaborate on Integrated OTC eCommerce Platform

Modernizing Medicine, Inc. and Galderma Laboratories, L.P. are teaming up to offer new capabilities in support of improved patient experiences and outcomes through healthcare provider recommended over…

Read the full story

Thursday, March 02, 2017 | Business of Medicine, Healthcare Trends, Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Galderma

Galderma, Colorescience to Collaborate on Innovative Skincare

Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable …

Read the full story

Monday, December 12, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Galderma

FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”

The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment…

Read the full story